28 related articles for article (PubMed ID: 2828590)
1. Detection of polymorphic epithelial mucins in the serum of systemic breast cancer patients using the monoclonal antibody, NCRC-11.
Price MR; Clarke AJ; Robertson JF; O'Sullivan C; Baldwin RW; Blamey RW
Cancer Immunol Immunother; 1990; 31(5):269-72. PubMed ID: 2376045
[TBL] [Abstract][Full Text] [Related]
2. Possible correlation of apical localization of MUC1 glycoprotein with luminal A-like status of breast cancer.
Semba R; Horimoto Y; Sakata-Matsuzawa M; Ishizuka Y; Denda-Nagai K; Fujihira H; Noji M; Onagi H; Ichida M; Miura H; Watanabe J; Saito M; Saito T; Arakawa A; Irimura T
Sci Rep; 2023 Mar; 13(1):5281. PubMed ID: 37002293
[TBL] [Abstract][Full Text] [Related]
3. miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1.
Xue L; Shen Y; Zhai Z; Zheng S
Int J Mol Med; 2020 Jun; 45(6):1771-1782. PubMed ID: 32236568
[TBL] [Abstract][Full Text] [Related]
4. Role of Sp1 expression in gastric cancer: A meta-analysis and bioinformatics analysis.
Shi S; Zhang ZG
Oncol Lett; 2019 Oct; 18(4):4126-4135. PubMed ID: 31579418
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival.
Shahinian JH; Fuellgraf H; Tholen S; Mastroianni J; Knopf JD; Kuehs M; Mayer B; Schlimpert M; Kulemann B; Kuesters S; Hoeppner J; Wellner UF; Werner M; Hopt UT; Zeiser R; Bronsert P; Schilling O
J Cancer; 2016; 7(14):2018-2027. PubMed ID: 27877217
[TBL] [Abstract][Full Text] [Related]
6. miRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer.
Guo L; Yuan J; Xie N; Wu H; Chen W; Song S; Wang X
Mol Med Rep; 2016 Oct; 14(4):2975-82. PubMed ID: 27572271
[TBL] [Abstract][Full Text] [Related]
7. Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.
Gandhy SU; Imanirad P; Jin UH; Nair V; Hedrick E; Cheng Y; Corton JC; Kim K; Safe S
Oncotarget; 2015 Sep; 6(28):26359-72. PubMed ID: 26317792
[TBL] [Abstract][Full Text] [Related]
8. Low SP1 expression differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.
Lee HS; Park CK; Oh E; Erkin ÖC; Jung HS; Cho MH; Kwon MJ; Chae SW; Kim SH; Wang LH; Park MJ; Lee SY; Yang HB; Jia L; Choi YL; Shin YK
PLoS One; 2013; 8(2):e55522. PubMed ID: 23437057
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor Sp3 regulates the expression of a metastasis-related marker of sarcoma, actin filament-associated protein 1-like 1 (AFAP1L1).
Kajita Y; Kato T; Tamaki S; Furu M; Takahashi R; Nagayama S; Aoyama T; Nishiyama H; Nakamura E; Katagiri T; Nakamura Y; Ogawa O; Toguchida J
PLoS One; 2013; 8(1):e49709. PubMed ID: 23326307
[TBL] [Abstract][Full Text] [Related]
10. Expression of epidermal growth factor receptor (proto-oncogene c-erbB-1) and estrogen receptor in human breast carcinoma. An immunocytochemical study of 70 cases.
Garcìa Castro C; Ravina M; Castro V; Salido EC
Arch Gynecol Obstet; 1993; 252(4):169-77. PubMed ID: 8512345
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.
Hale RJ; Buckley CH; Gullick WJ; Fox H; Williams J; Wilcox FL
J Clin Pathol; 1993 Feb; 46(2):149-53. PubMed ID: 8459036
[TBL] [Abstract][Full Text] [Related]
12. Expression of MUC2 epithelial mucin in breast carcinoma.
Walsh MD; McGuckin MA; Devine PL; Hohn BG; Wright RG
J Clin Pathol; 1993 Oct; 46(10):922-5. PubMed ID: 8227409
[TBL] [Abstract][Full Text] [Related]
13. Critical evaluation of monoclonal antibody staining in breast carcinoma.
Parham DM; Coghill G; Robertson AJ
J Clin Pathol; 1989 Aug; 42(8):810-3. PubMed ID: 2475527
[TBL] [Abstract][Full Text] [Related]
14. Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast.
Möller P; Mechtersheimer G; Kaufmann M; Moldenhauer G; Momburg F; Mattfeldt T; Otto HF
Virchows Arch A Pathol Anat Histopathol; 1989; 414(2):157-64. PubMed ID: 2464868
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in breast cancer: immunohistochemical staining for SP1 and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor status.
Wright C; Angus B; Napier J; Wetherall M; Udagawa Y; Sainsbury JR; Johnston S; Carpenter F; Horne CH
J Pathol; 1987 Dec; 153(4):325-31. PubMed ID: 2828590
[TBL] [Abstract][Full Text] [Related]
16. Survival in breast cancer related to tumour oestrogen receptor status and immunohistochemical staining for NCRC 11.
Angus B; Napier J; Purvis J; Ellis IO; Hawkins RA; Carpenter F; Horne CH
J Pathol; 1986 Aug; 149(4):301-6. PubMed ID: 3020217
[TBL] [Abstract][Full Text] [Related]
17. Relationships between oestrogen receptor,epidermal growth factor receptor, ER-D5, and P24 oestrogen regulated protein in human breast cancer.
Horne GM; Angus B; Wright C; Needham G; Nicholson S; Harris AL; Innes B; Horne CH
J Pathol; 1988 Jun; 155(2):143-50. PubMed ID: 3292735
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
[TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors.
Pirinen R; Lipponen P; Syrjänen K
Anticancer Res; 1995; 15(6B):2835-40. PubMed ID: 8669874
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
